AU744188C - Human growth gene and short stature gene region - Google Patents

Human growth gene and short stature gene region

Info

Publication number
AU744188C
AU744188C AU46252/97A AU4625297A AU744188C AU 744188 C AU744188 C AU 744188C AU 46252/97 A AU46252/97 A AU 46252/97A AU 4625297 A AU4625297 A AU 4625297A AU 744188 C AU744188 C AU 744188C
Authority
AU
Australia
Prior art keywords
seq
shox
dna
sequence
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU46252/97A
Other languages
English (en)
Other versions
AU744188B2 (en
AU4625297A (en
Inventor
Ercole Rao
Gudrun Rappold-Hoerbrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4625297A publication Critical patent/AU4625297A/en
Publication of AU744188B2 publication Critical patent/AU744188B2/en
Application granted granted Critical
Publication of AU744188C publication Critical patent/AU744188C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AU46252/97A 1996-10-01 1997-09-29 Human growth gene and short stature gene region Ceased AU744188C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2763396P 1996-10-01 1996-10-01
US60/027633 1996-10-01
EP97100583 1997-01-16
EP97100583 1997-01-16
PCT/EP1997/005355 WO1998014568A1 (en) 1996-10-01 1997-09-29 Human growth gene and short stature gene region

Publications (3)

Publication Number Publication Date
AU4625297A AU4625297A (en) 1998-04-24
AU744188B2 AU744188B2 (en) 2002-02-14
AU744188C true AU744188C (en) 2003-07-24

Family

ID=26145174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46252/97A Ceased AU744188C (en) 1996-10-01 1997-09-29 Human growth gene and short stature gene region

Country Status (20)

Country Link
US (2) US7252974B2 (enExample)
EP (2) EP1260228A3 (enExample)
JP (2) JP2000515025A (enExample)
KR (1) KR20000048838A (enExample)
CN (1) CN1232499A (enExample)
AT (1) ATE230026T1 (enExample)
AU (1) AU744188C (enExample)
BR (1) BR9712185A (enExample)
CA (2) CA2267097A1 (enExample)
CZ (1) CZ297640B6 (enExample)
DE (1) DE69718052T2 (enExample)
DK (1) DK0946721T3 (enExample)
ES (1) ES2188992T3 (enExample)
HU (1) HU225131B1 (enExample)
IL (1) IL129015A0 (enExample)
NO (1) NO991554L (enExample)
NZ (1) NZ334970A (enExample)
PL (1) PL194248B1 (enExample)
SI (1) SI0946721T1 (enExample)
WO (1) WO1998014568A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169346A4 (en) * 1999-03-19 2003-02-26 Human Genome Sciences Inc 48 HUMAN SECRETED PROTEINS
CA2368469A1 (en) * 1999-03-26 2000-10-05 Craig A. Rosen 50 human secreted proteins
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP1573024A4 (en) 2001-04-10 2007-08-29 Agensys Inc NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES
EP1439225A4 (en) 2001-10-04 2005-10-26 Kansai Tech Licensing Org Co DR5-GEN PROMOTER AND SIAH-1-GEN PROMOTER
EP1583554A2 (en) * 2003-01-13 2005-10-12 Gudrun Rappold-Hoerbrand Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
KR101708544B1 (ko) 2005-04-15 2017-02-20 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
US7382944B1 (en) 2006-07-14 2008-06-03 The United States Of America As Represented By The Administration Of The National Aeronautics And Space Administration Protective coating and hyperthermal atomic oxygen texturing of optical fibers used for blood glucose monitoring
PL2258871T3 (pl) * 2007-01-19 2014-10-31 Epigenomics Ag Sposoby i kwasy nukleinowe do analizy zaburzeń proliferacyjnych komórki
WO2014182595A1 (en) * 2013-05-06 2014-11-13 Mikko Sofia Diagnostic test for skeletal atavism in horses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445933A1 (de) * 1984-12-17 1986-06-19 Röhm GmbH, 6100 Darmstadt Arzneimittel mit diuretischer wirksamkeit
US4983511A (en) * 1989-01-09 1991-01-08 Olin Corporation Method and kit for detecting live microorganisms in chlorine- or bromine-treated water

Also Published As

Publication number Publication date
SI0946721T1 (en) 2003-06-30
CN1232499A (zh) 1999-10-20
JP2000515025A (ja) 2000-11-14
ES2188992T3 (es) 2003-07-01
IL129015A0 (en) 2000-02-17
AU744188B2 (en) 2002-02-14
NO991554L (no) 1999-05-14
ATE230026T1 (de) 2003-01-15
EP0946721A1 (en) 1999-10-06
EP1260228A2 (en) 2002-11-27
DK0946721T3 (da) 2003-04-14
EP1260228A3 (en) 2003-03-05
JP2004201692A (ja) 2004-07-22
CA2647169A1 (en) 1998-04-09
KR20000048838A (ko) 2000-07-25
AU4625297A (en) 1998-04-24
HUP9904175A3 (en) 2002-01-28
US20030059805A1 (en) 2003-03-27
DE69718052T2 (de) 2003-07-31
US7252974B2 (en) 2007-08-07
BR9712185A (pt) 1999-08-31
CZ297640B6 (cs) 2007-02-21
NO991554D0 (no) 1999-03-30
EP0946721B1 (en) 2002-12-18
NZ334970A (en) 2000-12-22
HUP9904175A2 (hu) 2000-04-28
CA2267097A1 (en) 1998-04-09
PL332568A1 (en) 1999-09-27
HU225131B1 (en) 2006-06-28
US20090111744A1 (en) 2009-04-30
CZ96699A3 (cs) 1999-08-11
PL194248B1 (pl) 2007-05-31
DE69718052D1 (de) 2003-01-30
WO1998014568A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
AU2021200783B2 (en) Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
RU2745324C2 (ru) Композиции и способы модулирования экспрессии tau
ES2792126T3 (es) Método de tratamiento basado en polimorfismos del gen KCNQ1
US20090111744A1 (en) Human Growth Gene and Short Stature Gene Region
US6262334B1 (en) Human genes and expression products: II
CA2348657C (fr) Clonage, expression et caracterisation du gene spg4 responsable de la forme la plus frequente de paraplegie spastique autosomique dominante
Class et al. Patent application title: Human Growth Gene and Short Stature Gene Region Inventors: Gudrun Rappold-Hoerbrand (Heidelberg, DE) Ercole Rao (Riedstadt, DE)
CN111278468A (zh) 用于脂肪营养不良的自体细胞疗法的人脂肪组织祖细胞
US6627745B1 (en) Pyrin gene and mutants thereof, which cause familial Mediterranean fever
MXPA99002809A (en) Human growth gene and short stature gene region
KR100968360B1 (ko) Ｈｅｒ-2 유전자 복제수 변화에 의해 발생되는 유방암의 진단 방법
HK1023146A (en) Human growth gene and short stature gene region
US20030104521A1 (en) Disease associated gene
US20030203380A1 (en) Gene linked to osteoarthritis
KR100909709B1 (ko) 골밀도 및 골절 위험과 ｉｔｇａ１ 유전자 다형성과의연관성
US20040191829A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20030224393A1 (en) Gene for peripheral arterial occlusive disease
CN116606920A (zh) 一种定性分析和定量分析基因rilpl1的试剂盒
CA2439155A1 (en) Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof
US20020142381A1 (en) Isolated nucleic acid molecules encoding human transporter proteins, and uses thereof
US20040248248A1 (en) Isolated human transporters proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20020173459A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20030148366A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins,and uses thereof
CA2400101A1 (en) Human protein tyrosine phosphatase, encoding dna and uses thereof
JP2002330794A (ja) 新規遺伝子及びそれにコードされる蛋白質

Legal Events

Date Code Title Description
SREP Specification republished
TH Corrigenda

Free format text: IN VOL 16, NO 3, PAGE(S) 589 UNDER THE HEADING APPLICATIONS ACCEPTED UNDER THE NAME RAPPOLD-HOERBRAND, G., SERIAL NO. 744188, INID (31), AMEND THE FIRST PRIORITY NUMBER TO READ 60/027633

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20021004

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20030109